Multiple Sclerosis Clinical Trial
Official title:
Outcomes of Group Dance and Movement Training in Ambulatory MS Patients
Verified date | November 2023 |
Source | GroundWorks DanceTheater |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
GroundWorks DanceTheater and Cleveland Clinic are partnering to create and offer an initial study of a dance movement-based community program for people with Multiple Sclerosis (MS). The program will address major needs in the MS community including social-emotional well-being, body awareness, and motor function. GroundWorks artists will use a variety of widely accepted movement-based practices with the goal of improving upper and lower body function and overall well-being. By partnering, GroundWorks and Cleveland Clinic hope to encourage more study of the benefits of dance movement-based programming in individuals affected by MS.
Status | Completed |
Enrollment | 6 |
Est. completion date | November 27, 2023 |
Est. primary completion date | July 14, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - age 18 to 65 inclusive - diagnosis of MS (relapsing or progressive form) based on the revised MacDonald Criteria established by a neurologist - self-reported upper and lower extremity dysfunction - ability to walk safely without an assistive device (e.g. cane, walker) indoors and outdoors Exclusion Criteria: - comorbidity (e.g. cardiac, respiratory, musculoskeletal) representing a contra-indication to the dance movement program - exacerbation of MS within the past 60 days - severe cognitive impairment - clinically significant concern regarding the participant's ability to safely perform study procedures |
Country | Name | City | State |
---|---|---|---|
United States | Cleveland State University | Cleveland | Ohio |
Lead Sponsor | Collaborator |
---|---|
GroundWorks DanceTheater |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Timed Up and Go (TUG) | This is a test of functional mobility, commonly used for people with MS. The test measures the time it takes for a person to stand up from a chair, walk 10 feet, turn around, walk back to the chair and sit down. | 4 months | |
Primary | 9 Hole Peg Test (NHPT) | This is a widely used test of upper extremity function in people with MS. The test measures the time it takes for a person to pick up 9 pegs individually and place each one in one of 9 holes on a board and then take each one out, one at a time, and place the pegs back in the container. | 4 months | |
Secondary | Neuro-QOL Positive Affect and Well-Being - Short Form | This is a self-reported quality of life measure which has been validated in people with MS to assess positive affect and well-being. | 4 months | |
Secondary | Neuro-QOL Lower Extremity Function (Mobility) - Short Form | This is a self-reported quality of life measure which has been validated in people with MS to assess mobility. | 4 months | |
Secondary | Neuro-QOL Upper Extremity Function (Fine Motor, ADL) - Short Form | This is a self-reported quality of life measure which has been validated in people with MS to assess fine motor and ADLs. | 4 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT03269175 -
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies
|
Phase 4 |